The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Evidence‐based guidelines for the use of immunologic tests: Antinuclear antibody testing
Abstract
This article is part of a series on immunologic testing guidelines. The series introduction, published in this issue, outlines the full methodology for obtaining data, grading the literature, combining the information from multiple sources, and developing recommendations. Briefly, MEDLINE and Healthstar were searched using a variety of search terms, and all relevant available literature was reviewed. All articles were critically reviewed using published standards for studies of diagnostic tests. Test use was categorized as primarily diagnostic or prognostic (which also included monitoring). Information was extracted from each article to allow for calculation of a weighted average for sensitivity and specificity; likelihood ratios (LRs) were then derived from these values (positive LR sensitivity / [1-specificity]; negative LR [1-sensitivity] / specificity). Recommendations for use of tests were based on the LRs, where a test was considered to be “very useful” for a given disease if the weighted average positive LR was 5 or negative LR was 0.2. A test was considered “useful” if the weighted average positive LR was 2 and 5 or negative LR was 0.2 and 0.5. A test was considered “not useful” if the positive LR was 2 or the negative LR was 0.5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
(2016) · Diagnostic Imaging: Brain · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
Sharp, G. C., Irvin, W. S., Tan, E. M., Gould, R. G., & Holman, H. R. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90064-2 · Cited by 1,835
Love, L. A., Leff, R. L., Fraser, D. D., Targoff, I. N., Dalakas, M., Plotz, P. H., & Miller, F. W. (1991) · Medicine · doi:10.1097/00005792-199111000-00002 · Cited by 969
Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing
Trounce, I., Byrne, E., & Marzuki, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92143-0 · Cited by 730
Diversity of antinuclear antibodies in progressive systemic sclerosis
Tan, E. M., Rodnan, G. P., Garcia, I., Moroi, Y., Fritzler, M. J., & Peebles, C. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230602 · Cited by 524
Block, J. A., & Sequeira, W. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05118-7 · Cited by 422
HOCHBERG, M. C., BOYD, R. E., AHEARN, J. M., ARNETT, F. C., BIAS, W. B., PROVOST, T. T., & STEVENS, M. B. (1985) · Medicine · doi:10.1097/00005792-198509000-00001 · Cited by 398
The CREST syndrome: A distinct serologic entity with anticentromere antibodies
Fritzler, M. J., Kinsella, T. D., & Garbutt, E. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90462-3 · Cited by 366
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C†
Clifford, B. D., Donahue, D., Smith, L., Cable, E., Luttig, B., Manns, M., & Bonkovsky, H. L. (1995) · Hepatology · doi:10.1002/hep.1840210302 · Cited by 354
Giordano, M., Valentini, G., Migliaresi, S., et al. (1986) · PubMed · Cited by 196
Fritzler, M. J., Pauls, J. D., Kinsella, T. D., & Bowen, T. J. (1985) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(85)90045-5 · Cited by 183
Tan, E. M., Smolen, J. S., McDougal, J. S., Butcher, B. T., Conn, D. L., Dawkins, R. L., Fritzler, M. J., Gordon, T., Hardin, J., Kalden, J. R., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:3<455::aid-anr10>3.0.co;2-3 · Cited by 175
Emlen, W., & O'Neill, L. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400910 · Cited by 139
Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma)
Rothfield, N. F., & Rodnan, G. P. (1968) · Arthritis & Rheumatism · doi:10.1002/art.1780110502 · Cited by 139
Dinerman, H., Goldenberg, D. L., & Felson, D. T. (1986) · PubMed · Cited by 133
Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features.
Molina, R., Provost, T., Arnett, F., Bias, W., Hochberg, M., Wilson, R. W., & Alexander, E. (1986) · American Journal of Medicine · doi:10.1016/0002-9343(86)90044-6 · Cited by 116
FAMILY STUDIES IN SYSTEMIC LUPUS ERYTHEMATOSUS.
Leonhardt, T. (1964) · PubMed · Cited by 116
Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis.
Bernstein, R. M., Neuberger, J., Bunn, C., Callender, M. E., Hughes, G. R. V., & Williams, R. L. (1984) · PubMed Central · Cited by 110
Evolution of primary raynaud's phenomenon (raynaud's disease) to connective tissue disease
Gerbracht, D. D., Steen, V. D., Ziegler, G. C., Medsger, T. A., & Rodnan, G. P. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280114 · Cited by 101
Bulpitt, K. J., Clements, P. J., Lachenbruch, P. A., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-8-199304150-00005 · Cited by 92
Frequency and significance of antinuclear antibodies in multiple sclerosis
Collard, R. C., Koehler, R. P. M., & Mattson, D. H. (1997) · Neurology · doi:10.1212/wnl.49.3.857 · Cited by 78
Imai, H., Nakano, Y., Kiyosawa, K., & Tan, E. M. (1993) · Cancer · doi:10.1002/1097-0142(19930101)71:1<26::aid-cncr2820710106>3.0.co;2-n · Cited by 76
Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon
Kallenberg, C. G. M., Wouda, A. A., & THE, T. H. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90417-9 · Cited by 66
Antinuclear Antibodies in Multiple Sclerosis
Dore‐Duffy, P., Donaldson, J. O., Rothman, B. L., & Zurier, R. B. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510200046008 · Cited by 61
Clegg, D. O., Williams, H. J., Singer, J. Z., et al. (1991) · PubMed · Cited by 60
Guidelines for immunologic laboratory testing in the rheumatic diseases: An introduction
(2002) · Arthritis Care & Research · doi:10.1002/art.10381 · Cited by 60
ANTIBODIES IN THE FAMILIES OF THYROTOXIC PATIENTS
Evans, A. W. H., Woodrow, J. C., Mcdougall, C. D. M., et al. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92539-1 · Cited by 59
Autoantibody tests in autoimmune thyroid disease: a case-control study.
Petri, M., Karlson, E. W., Cooper, D. S., & Ladenson, P. W. (1991) · PubMed · Cited by 59
Discovery of the LE cell and its morphology.
Hargraves, M. M. (1969) · PubMed · Cited by 57
Jónsson, H., Nived, O., & Sturfelt, G. K. (1988) · PubMed · Cited by 57
Bayraktar, Y., Bayraktar, M., Gurakar, A. O., Hassanein, T., & Thiel, D. H. V. (1997) · PubMed · Cited by 56
Wollersheim, H. C. H., Thien, T., Hoet, M. H., et al. (1989) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1989.tb00271.x · Cited by 55
Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome
Ben‐Chetrit, E., Fischel, R., & Rubinow, A. (1993) · Clinical Rheumatology · doi:10.1007/bf02231773 · Cited by 53
Yunus, M. B., Hussey, F. X., & Aldag, J. C. (1993) · PubMed · Cited by 45
Malleson, P. N., Petty, R. E., Fung, M., et al. (1989) · Arthritis & Rheumatology · doi:10.1002/j.2326-5205.1989.tb00025.x · Cited by 42
Diversity of antinucelar antibody responses in hepatocellular carcinoma
Covini, G., von Mühlen, C. A., Pacchetti, S., Colombo, M. G., Chan, E. K. L., & Tan, E. M. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80460-6 · Cited by 41
Clinical and serologic features of patients with polymyositis or dermatomyositis.
Holden, D. J., Brownell, A. K. W., & Fritzler, M. J. (1985) · PubMed · Cited by 40
Circulating immune complexes and antinuclear antibodies in juvenile rheumatoid arthritis
Rossen, R. D., Brewer, E. J., Person, D. A., et al. (1977) · Arthritis & Rheumatism · doi:10.1002/art.1780200807 · Cited by 39
Lock, R. J., & Unsworth, D. J. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.3.187 · Cited by 28
Weitzman, R. J., & Walker, S. E. (1977) · Annals of the Rheumatic Diseases · doi:10.1136/ard.36.1.44 · Cited by 27
Sulcebe, G., & Morcka, K. (1992) · PubMed · Cited by 26
Juby, A. G., Johnston, C. A., & Davis, P. (1991) · PubMed · Cited by 22
Antibodies to a 15 kD nuclear antigen in patients with juvenile chronic arthritis and uveitis.
Neuteboom, G. H. G., Cate, R. H.-T., de Jong, J. L., et al. (1992) · PubMed · Cited by 18
Diagnosis of Systemic Lupus Erythematosus
Nisengard, R. J. (1975) · Archives of Dermatology · doi:10.1001/archderm.1975.01630220062003 · Cited by 13
Cited by
Fischer, A., Antoniou, K. M., Brown, K. K., Cadranel, J., Corte, T. J., du Bois, R. M., Lee, J. S., Leslie, K. O., Lynch, D. A., Matteson, E. L., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00150-2015 · Cited by 1,099
Agmon-Levin, N., Damoiseaux, J., Kallenberg, C., Sack, U., Witte, T., Herold, M., Bossuyt, X., Musset, L., Cervera, R., Plaza-Lopez, A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203863 · Cited by 615
ANA screening: an old test with new recommendations
Meroni, P. L., & Schur, P. H. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.127100 · Cited by 533
Self-citationDamoiseaux, J., Andrade, L. E. C., Carballo, O. G., Conrad, K., Francescantonio, P. L. C., Fritzler, M. J., Garcia de la Torre, I., Herold, M., Klotz, W., Cruvinel, W. D. M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214436 · Cited by 378
Kinder, B. W., Collard, H. R., Koth, L., Daikh, D. I., Wolters, P. J., Elicker, B., Jones, K. D., & King, T. E. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-220oc · Cited by 381
Metadata
- Authors
- Solomon, D. H., Kavanaugh, A. J., Schur, P. H., & American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2002-08-12
- Volume
- 47
- Issue
- 4
- Pages
- 434-444
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W2001414865
- Cited by
- 510
- References
- 45
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.